{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T09:14:11Z","timestamp":1648977251710},"reference-count":31,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2021.10712","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T07:28:52Z","timestamp":1631086132000},"source":"Crossref","is-referenced-by-count":1,"title":["Vasculitis associated with the use of an\u00a0intrauterine device: A case report"],"prefix":"10.3892","volume":"22","author":[{"given":"Aurelian","family":"Ghita","sequence":"first","affiliation":[{"name":"Department of Physiology II, Faculty of Medicine, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Alexandrescu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Dentistry, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanziana","family":"Istrate","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Dentistry, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca","family":"Evsei","sequence":"additional","affiliation":[{"name":"Department of Pathology, \u2018Sf. Maria\u2019 Clinical Hospital, 011172 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Ghita","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ocularcare Eye Clinic, 011204 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"issue":"S9","key":"key20211014132558_b1-ETM-0-0-10712","doi-asserted-by":"publisher","DOI":"10.1186\/ar2193","article-title":"Vasculitis: Mechanisms involved and clinical manifestations","volume":"9 (Suppl 2)","author":"Guillevin","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"key20211014132558_b2-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"S216","DOI":"10.1016\/j.jaci.2009.07.002","article-title":"Vasculitis","volume":"125 (Suppl 2)","author":"Langford","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"key20211014132558_b3-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ajoc.2016.04.007","article-title":"Vasculitic central retinal vein occlusion: The presenting sign of seronegative rheumatoid arthritis","volume":"2","author":"Trese","year":"2016","journal-title":"Am J Ophthalmol Case Rep"},{"key":"key20211014132558_b4-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/BOR.0000000000000271","article-title":"Retinal vasculitis","volume":"28","author":"Rosenbaum","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"key20211014132558_b5-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10157-013-0869-6","article-title":"Overview of the 2012 revised International chapel hill consensus conference nomenclature of vasculitides","volume":"17","author":"Jennette","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"key20211014132558_b6-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"739","DOI":"10.4103\/0301-4738.120216","article-title":"Clinical features and etiology of retinal vasculitis in Northern Thailand","volume":"61","author":"Apinyawasisuk","year":"2013","journal-title":"Indian J Ophthalmol"},{"issue":"2783","key":"key20211014132558_b7-ETM-0-0-10712","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59666-0","article-title":"Analysis of inflammatory mediators in the vitreous humor of eyes with pan-uveitis according to aetiological classification","volume":"10","author":"Fukunaga","year":"2020","journal-title":"Sci Rep"},{"key":"key20211014132558_b8-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s10384-020-00717-4","article-title":"Retinal vascular inflammatory and occlusive changes in infectious and non-infectious uveitis","volume":"64","author":"Kaburaki","year":"2020","journal-title":"Jpn J Ophthalmol"},{"key":"key20211014132558_b9-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/ceo.12997","article-title":"Epidemiology and clinical features of inflammatory retinal vascular occlusions: Pooled data from two tertiary-referral institutions","volume":"46","author":"Agarwal","year":"2018","journal-title":"Clin Exp Ophthalmol"},{"issue":"71","key":"key20211014132558_b10-ETM-0-0-10712","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-015-0545-9","article-title":"Drug-induced vasculitis: New insights and a changing lineup of suspects","volume":"17","author":"Grau","year":"2015","journal-title":"Curr Rheumatol Rep"},{"issue":"e000250","key":"key20211014132558_b11-ETM-0-0-10712","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2018-000250","article-title":"New onset or exacerbation of uveitis with infliximab: Paradoxical effects?","volume":"4","author":"Iwahashi","year":"2019","journal-title":"BMJ Open Ophthalmol"},{"key":"key20211014132558_b12-ETM-0-0-10712","author":"Agarwal"},{"key":"key20211014132558_b13-ETM-0-0-10712","first-page":"451","article-title":"Vasculitis with cutaneous necrosis induced by oral contraceptive","volume":"120","author":"Mosovich","year":"1991","journal-title":"Harefuah"},{"key":"key20211014132558_b14-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/20009666.2017.1422673","article-title":"Propylthiouracil-induced ANCA-negative cutaneous small vessel vasculitis","volume":"8","author":"Trusau","year":"2018","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"key20211014132558_b15-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/BOR.0b013e3282f1331f","article-title":"Drug-induced vasculitis","volume":"20","author":"Wiik","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"key20211014132558_b16-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2147\/ppa.s3464","article-title":"Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system","volume":"2","author":"Kailasam","year":"2008","journal-title":"Patient Prefer Adherence"},{"key":"key20211014132558_b17-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/0010-7824(94)90109-0","article-title":"Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: A randomized comparative trial","volume":"49","author":"Andersson","year":"1994","journal-title":"Contraception"},{"key":"key20211014132558_b18-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"430","DOI":"10.2165\/00002018-199615060-00006","article-title":"A risk-benefit assessment of the levonorgestrel-releasing intrauterine system","volume":"15","author":"Sturridge","year":"1996","journal-title":"Drug Saf"},{"key":"key20211014132558_b19-ETM-0-0-10712","author":"Vrettakos"},{"key":"key20211014132558_b20-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4103\/0974-9233.58423","article-title":"Differential diagnosis of retinal vasculitis","volume":"16","author":"Abu El-Asrar","year":"2009","journal-title":"Middle East Afr J Ophthalmol"},{"key":"key20211014132558_b21-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/IJWH.S122579","article-title":"Intrauterine levonorgestrel delivery with frameless fibrous delivery system: Review of clinical experience","volume":"9","author":"Wildemeersch","year":"2017","journal-title":"Int J Womens Health"},{"key":"key20211014132558_b22-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3892\/etm.2018.6988","article-title":"Cutaneous leukocytoclastic vasculitis associated with erlotinib treatment: A case report and review of the literature","volume":"17","author":"Fekete","year":"2019","journal-title":"Exp Ther Med"},{"key":"key20211014132558_b23-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.contraception.2011.08.003","article-title":"The benefits and risks of using a levonorgestrel-releasing intrauterine system for contraception","volume":"85","author":"Mansour","year":"2012","journal-title":"Contraception"},{"key":"key20211014132558_b24-ETM-0-0-10712","first-page":"12","article-title":"Drug-induced vasculitis: A clinical and pathological review","volume":"70","author":"Radic","year":"2012","journal-title":"Neth J Med"},{"key":"key20211014132558_b25-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/ICU.0000000000000422","article-title":"Ophthalmologic manifestations of systemic vasculitis","volume":"28","author":"Papaliodis","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"key20211014132558_b26-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/BOR.0000000000000345","article-title":"Systemic vasculitis and the eye","volume":"29","author":"Tugal-Tutkun","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"key20211014132558_b27-ETM-0-0-10712","first-page":"6","article-title":"Cogan's syndrome","volume":"59","author":"Iliescu","year":"2015","journal-title":"Rom J Ophthalmol"},{"key":"key20211014132558_b28-ETM-0-0-10712","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0889-857X(21)01068-1","article-title":"Vasculitis and Cogan's syndrome","volume":"16","author":"Vollertsen","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"key":"key20211014132558_b29-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s11096-018-0694-9","article-title":"Comparison of different methods for causality assessment of adverse drug reactions","volume":"40","author":"Behera","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"e00373","key":"key20211014132558_b30-ETM-0-0-10712","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.373","article-title":"Improving the assessment of adverse drug reactions using the Naranjo Algorithm in daily practice: The Japan adverse drug events study","volume":"6","author":"Murayama","year":"2018","journal-title":"Pharmacol Res Perspect"},{"key":"key20211014132558_b31-ETM-0-0-10712","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T13:25:34Z","timestamp":1634217934000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2021.10712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,9,8]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2021.10712","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,8]]},"article-number":"1277"}}